Iron Deficiency Defined by Hepcidin in Critically Ill Patients.
作者信息
Eisenga Michele F
机构信息
Department of Internal Medicine, Division of Nephrology, University Medical Center Groningen, P.O. Box 30.001, 9700 RB, Groningen, The Netherlands.
出版信息
Crit Care. 2021 Apr 12;25(1):138. doi: 10.1186/s13054-021-03542-4.
Abstract
摘要
相似文献
1
Iron Deficiency Defined by Hepcidin in Critically Ill Patients.由铁调素定义的危重症患者缺铁情况
Crit Care. 2021 Apr 12;25(1):138. doi: 10.1186/s13054-021-03542-4.
2
Diagnostic accuracy of serum hepcidin for iron deficiency in critically ill patients with anemia.血清铁调素对贫血危重症患者缺铁的诊断准确性。
Intensive Care Med. 2010 Jun;36(6):1044-8. doi: 10.1007/s00134-010-1794-8. Epub 2010 Mar 6.
3
Iron deficiency diagnosed using hepcidin on critical care discharge is an independent risk factor for death and poor quality of life at one year: an observational prospective study on 1161 patients.铁缺乏症使用铁调素在重症监护病房出院时诊断是死亡和一年时生活质量差的独立危险因素：对 1161 例患者的观察性前瞻性研究。
Crit Care. 2018 Nov 21;22(1):314. doi: 10.1186/s13054-018-2253-0.
4
Impact of iron deficiency diagnosis using hepcidin mass spectrometry dosage methods on hospital stay and costs after a prolonged ICU stay: Study protocol for a multicentre, randomised, single-blinded medico-economic trial.采用铁调素质谱测定法诊断缺铁对 ICU 长时间住院患者住院时间和费用的影响：一项多中心、随机、单盲医学经济学试验的研究方案。
Anaesth Crit Care Pain Med. 2017 Dec;36(6):391-396. doi: 10.1016/j.accpm.2017.04.009. Epub 2017 Sep 14.
5
Iron deficiency in critically ill patients: highlighting the role of hepcidin.危重症患者的缺铁：强调铁调素的作用
Crit Care. 2011;15(2):210. doi: 10.1186/cc9992. Epub 2011 Mar 22.
6
Targeted treatment of iron deficiency in prolonged critical illness: an opportunity to improve survival or not?长期危重症中铁缺乏的靶向治疗：是改善生存的契机还是并非如此？
Crit Care. 2021 Jun 1;25(1):188. doi: 10.1186/s13054-021-03590-w.
7
Analytical comparison of ELISA and mass spectrometry for quantification of serum hepcidin in critically ill patients.酶联免疫吸附测定法（ELISA）与质谱分析法在危重症患者血清铁调素定量分析中的比较
Bioanalysis. 2021 Jul;13(13):1029-1035. doi: 10.4155/bio-2021-0069. Epub 2021 Jun 8.
8
Serum hepcidin potentially identifies iron deficiency in survivors of critical illness at the time of hospital discharge.血清铁调素可能在出院时识别危重症幸存者的缺铁情况。
Br J Haematol. 2019 Jan;184(2):279-281. doi: 10.1111/bjh.15067. Epub 2018 Jan 24.
9
Unfractionated heparin reduces hepcidin levels in critically ill patients.未分级肝素可降低危重症患者的铁调素水平。
Intern Med J. 2021 May;51(5):797-801. doi: 10.1111/imj.15317.
10
Hepcidin as a biochemical parameter for the assessment of iron deficiency anemia.铁调素作为评估缺铁性贫血的生化参数。
Rev Assoc Med Bras (1992). 2010 Sep-Oct;56(5):596-9. doi: 10.1590/s0104-42302010000500024.
引用本文的文献
1
Iron Metabolism in the Recovery Phase of Critical Illness with a Focus on Sepsis.危重病康复期铁代谢：以脓毒症为例。
Int J Mol Sci. 2024 Jun 26;25(13):7004. doi: 10.3390/ijms25137004.
本文引用的文献
1
Impact of treating iron deficiency, diagnosed according to hepcidin quantification, on outcomes after a prolonged ICU stay compared to standard care: a multicenter, randomized, single-blinded trial.根据铁调素定量诊断缺铁后进行治疗对延长 ICU 住院时间患者结局的影响：一项多中心、随机、单盲试验。
Crit Care. 2021 Feb 15;25(1):62. doi: 10.1186/s13054-020-03430-3.
2
Iron deficiency diagnosed using hepcidin on critical care discharge is an independent risk factor for death and poor quality of life at one year: an observational prospective study on 1161 patients.铁缺乏症使用铁调素在重症监护病房出院时诊断是死亡和一年时生活质量差的独立危险因素：对 1161 例患者的观察性前瞻性研究。
Crit Care. 2018 Nov 21;22(1):314. doi: 10.1186/s13054-018-2253-0.
3
Low hepcidin in liver fibrosis and cirrhosis; a tale of progressive disorder and a case for a new biochemical marker.肝纤维化和肝硬化中的低铁调素；一种进行性紊乱的故事和一个新的生化标志物的案例。
Mol Med. 2018 Mar 15;24(1):5. doi: 10.1186/s10020-018-0008-7.
4
Definition of Iron Deficiency Based on the Gold Standard of Bone Marrow Iron Staining in Heart Failure Patients.基于心力衰竭患者骨髓铁染色金标准的缺铁定义。
Circ Heart Fail. 2018 Feb;11(2):e004519. doi: 10.1161/CIRCHEARTFAILURE.117.004519.
5
Urinary prednisolone excretion is a determinant of serum hepcidin levels in renal transplant recipients.尿中泼尼松龙排泄是肾移植受者血清铁调素水平的一个决定因素。
Am J Hematol. 2017 Aug;92(8):E173-E175. doi: 10.1002/ajh.24785. Epub 2017 Jun 9.
6
Hepcidin in the diagnosis of iron disorders.铁调素在铁代谢紊乱诊断中的应用
Blood. 2016 Jun 9;127(23):2809-13. doi: 10.1182/blood-2015-12-639112. Epub 2016 Apr 4.
7
Hepcidin and anemia of the critically ill patient: bench to bedside.铁调素与危重症患者贫血：从 bench 到 bedside。 （注：“bench to bedside”直译为“从实验室到临床床边”，这里意译为“从基础研究到临床应用”更符合语境）
完整译文：铁调素与危重症患者贫血：从基础研究到临床应用
Anesthesiology. 2011 Mar;114(3):688-94. doi: 10.1097/ALN.0b013e3182065c57.
8
Diagnostic accuracy of serum hepcidin for iron deficiency in critically ill patients with anemia.血清铁调素对贫血危重症患者缺铁的诊断准确性。
Intensive Care Med. 2010 Jun;36(6):1044-8. doi: 10.1007/s00134-010-1794-8. Epub 2010 Mar 6.
Zotero 插件